Participation of chemical mediators other than histamine in nasal allergy signs:: a study using mice lacking histamine H1 receptors

被引:23
作者
Kayasuga, R
Sugimoto, Y
Watanabe, T
Kamei, C [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmacol, Okayama 7008530, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Mol Immunol, Fukuoka 8128582, Japan
关键词
nasal allergic sign; histamine H-1 receptor; thromboxane A(2); leukotriene;
D O I
10.1016/S0014-2999(02)02005-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the involvement of chemical mediators other than histamine in nasal allergic signs using histamine H-1 receptor-deficient mice. In passively sensitized mice, antigen instillation into the nasal cavity induced significant increases in sneezing and nasal rubbing in wild-type mice, but no such increases were observed in histamine H-1 receptor-deficient mice. In actively sensitized mice, both sneezing and nasal rubbing were also significantly increased in a dose-dependent manner in both wild-type and histamine H-1 receptor-deficient mice. Histamine H-1 receptor antagonists such as cetirizine and epinastine significantly inhibited antigen-induced nasal allergic signs in wild-type mice, although the effects were incomplete. In addition, the thromboxane A(2) receptor antagonist ramatroban also inhibited these responses in wild-type mice. However, the leukotriene receptor antagonist zafirlukast showed no effects in wild-type mice. These results suggested that in the acute allergic model (passive sensitization), only histamine H-1 receptors are related to nasal signs induced by antigen, whereas in the chronic allergic model (active sensitization), both histamine H-1 receptors and thromboxane A(2) receptors were involved in the responses. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 18 条
[11]   Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial [J].
Meltzer, EO ;
Malmstrom, K ;
Lu, S ;
Prenner, BM ;
Wei, LX ;
Weinstein, SF ;
Wolfe, JD ;
Reiss, TF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) :917-922
[12]   Vascular permeability in allergic conjunctivitis in mice lacking histamine H1 receptors [J].
Nakahara, H ;
Izushi, K ;
Sugimoto, Y ;
Watanabe, T ;
Kamei, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 409 (03) :313-317
[13]   Effects of thromboxane A(2) receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs [J].
Narita, S ;
Asakura, K ;
Kataura, A .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 109 (02) :161-166
[14]   ACTIVE ANAPHYLAXIS IN IGE-DEFICIENT MICE [J].
OETTGEN, HC ;
MARTIN, TR ;
WYNSHAWBORIS, A ;
DENG, CX ;
DRAZEN, JM ;
LEDER, P .
NATURE, 1994, 370 (6488) :367-370
[15]   Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis [J].
Pullerits, T ;
Praks, L ;
Skoogh, BE ;
Ani, R ;
Lötvall, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) :1814-1818
[16]   A new model of allergic rhinitis in rats by topical sensitization and evaluation of H1-receptor antagonists [J].
Sugimoto, Y ;
Kawamoto, E ;
Chen, Z ;
Kamei, C .
IMMUNOPHARMACOLOGY, 2000, 48 (01) :1-7
[17]   THE ROLE OF HISTAMINE IN ALLERGIC DISEASES [J].
WHITE, MV .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (04) :599-605
[18]   Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis [J].
Yamasaki, M ;
Mizutani, N ;
Sasaki, K ;
Nabe, T ;
Matsumoto, T ;
Ashida, Y ;
Kohno, S .
INFLAMMATION RESEARCH, 2001, 50 (09) :466-473